BIOMAT Database Logo BIOMAT Database Logo

Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection. 1988

S J Hadziyannis
Academic Department of Medicine, Hippokration General Hospital, Athens, Greece.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006716 Homosexuality The sexual attraction or relationship between members of the same SEX. Homosexuality, Ego-Dystonic,Ego-Dystonic Homosexuality,Homosexuality, Ego Dystonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

S J Hadziyannis
Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
September 1989, BMJ (Clinical research ed.),
S J Hadziyannis
Human lymphoblastoid interferon therapy in chronic hepatitis B virus carriers.
December 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
S J Hadziyannis
Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
May 1987, Gut,
S J Hadziyannis
Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
January 1986, Journal of hepatology,
S J Hadziyannis
A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
January 1986, Journal of hepatology,
S J Hadziyannis
An open study of human lymphoblastoid interferon and oral acyclovir in chronic hepatitis B virus infection.
January 1986, Journal of hepatology,
S J Hadziyannis
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy.
September 1989, Hepatology (Baltimore, Md.),
S J Hadziyannis
Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.
January 1989, BMJ (Clinical research ed.),
S J Hadziyannis
Chronic hepatitis B virus infection and interferon-alpha.
October 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
S J Hadziyannis
[Treatment of chronic hepatitis B with lymphoblastoid alpha interferon].
November 1989, Medicina clinica,
Copied contents to your clipboard!